Agilon Health AGL Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $211.57M+52.6% | $173.71M-10.4% | $171.68M+11.6% | $171.42M+47.3% | $138.62M+16.9% | ||
| $899.75M-27.4% | $673.79M-33.7% | $947.16M-30.8% | $1.05B-27.1% | $1.24B-21.1% | ||
| $1.32B-20.0% | $1.1B-24.8% | $1.34B-26.1% | $1.45B-22.9% | $1.65B-19.0% | ||
| $24.89M-11.4% | $25.42M-9.8% | $26.15M-7.3% | $27.41M-1.5% | $28.09M+2.0% | ||
| $62.45M-8.4% | $65.73M-9.7% | $75.25M+2.5% | $65.6M-12.3% | $68.19M-5.4% | ||
| $1.5B-22.1% | $1.27B-26.7% | $1.6B-23.7% | $1.71B-20.8% | $1.93B-16.6% | ||
| $202.48M-10.7% | $127.48M-42.1% | $145.52M-33.4% | $171.89M-38.8% | $226.69M-10.2% | ||
| $14.75M— | $19.24M— | $34.97M— | —— | —— | ||
| $1.27B-7.4% | $1.08B-6.6% | $1.24B-12.0% | $1.25B-10.0% | $1.37B-10.0% | ||
| $15.28M— | $15.75M-54.9% | $0-100% | $0-100% | $0-100% | ||
| $1.32B-7.6% | $1.14B-9.4% | $1.29B-14.9% | $1.3B-12.3% | $1.43B-12.0% | ||
| 2B0.0% | 2B+48,420% | 2B0.0% | 2B0.0% | 2B0.0% | ||
| -$1.93B-22.5% | -$1.98B-24.7% | -$1.79B-20.8% | -$1.68B-23.1% | -$1.57B-18.2% | ||
| $181.43M-63.7% | $126.73M-73.1% | $306.08M-46.8% | $408.93M-39.6% | $500.25M-27.4% | ||
| $1.5B-22.1% | $1.27B-26.7% | $1.6B-23.7% | $1.71B-20.8% | $1.93B-16.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Agilon Health cover its short-term obligations?
- Its current ratio is 1.04 — current assets exceed current liabilities.
- Where does Agilon Health's balance sheet data come from?
- Every line is extracted from Agilon Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.